Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer
C Tournoux-Facon, G Robinet, MC Pinel… - American Journal of …, 2012 - journals.lww.com
Objective Vinflunine (VFL)(Javlor®), a novel fluorinated semisynthetic vinca alkaloid has
shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We …
shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We …
Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer.
C Tournoux-Facon, G Robinet, MC Pinel… - American Journal of …, 2012 - europepmc.org
Objective Vinflunine (VFL)(Javlor (®)), a novel fluorinated semisynthetic vinca alkaloid has
shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We …
shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We …
Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer
C Tournoux-Facon, G Robinet… - … journal of clinical …, 2012 - pubmed.ncbi.nlm.nih.gov
Objective Vinflunine (VFL)(Javlor (®)), a novel fluorinated semisynthetic vinca alkaloid has
shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We …
shown significant antitumor activity in advanced non-small cell lung cancer (NSCLC). We …